Regeneron Pharmaceuticals, Inc. (REGN) Social Stream



Regeneron Pharmaceuticals, Inc. (REGN): $646.95

6.06 (+0.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add REGN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 503

in industry

Regeneron Pharmaceuticals Inc (REGN) Price Targets From Analysts

Use the tables below to see what analysts covering Regeneron Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
24 $825 $545 $677.04 $651.88 3.86%

The Trend in the Analyst Price Target


Over the past 70 days, REGN's average price target has gone up $44.13.

REGN reports an average of 20.21% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 24 825 545 677.04 650.49 4.08%
2021-09-04 24 906 545 681.75 679.57 0.32%
2021-08-28 24 906 545 681.75 663.29 2.78%
2021-08-14 23 906 545 674.61 624.79 7.97%
2021-08-07 24 906 545 668.71 610.86 9.47%
2021-08-05 23 828 460 642.83 602.47 6.7%
2021-08-01 23 828 460 642.30 574.61 11.78%
2021-07-24 23 828 460 641.17 586.35 9.35%
2021-07-17 23 814 460 638.39 583.24 9.46%
2021-07-10 23 814 460 638.39 580.40 9.99%
2021-07-03 23 814 460 632.91 583.64 8.44%
2021-06-26 22 814 460 629.73 550.55 14.38%
2021-06-13 22 814 460 628.36 525.55 19.56%
2021-06-05 22 814 460 628.36 511.89 22.75%
2021-05-22 22 814 460 628.36 506.72 24.01%
2021-05-15 22 814 460 628.36 516.62 21.63%
2021-05-08 22 794 460 628.46 496.75 26.51%
2021-04-25 22 794 477 643.36 488.64 31.66%
2021-04-17 22 794 477 643.36 502.60 28.01%
2021-04-10 23 795 525 647.96 475.17 36.36%
2021-04-03 23 795 525 647.96 474.93 36.43%
2021-03-20 23 795 525 647.87 473.70 36.77%
2021-03-13 23 795 525 647.22 471.46 37.28%
2021-03-06 23 795 525 647.22 461.57 40.22%
2021-02-27 24 795 525 650.83 450.57 44.45%
2020-11-26 22 793 550 673.86 508.31 32.57%
2020-11-23 24 793 550 674.00 523.61 28.72%
2020-11-13 23 793 550 675.00 566.43 19.17%
2020-10-19 24 800 550 673.50 583.14 15.5%
2020-10-05 24 800 550 672.71 605.08 11.18%
2020-09-23 24 800 550 672.54 565.19 18.99%
2020-09-14 24 800 550 672.54 NA NA%
2020-08-26 24 800 550 672.54 NA NA%
2020-08-15 24 800 550 672.54 NA NA%
2020-08-06 24 800 550 672.54 NA NA%
2020-07-22 24 750 501 637.00 NA NA%
2020-07-17 24 750 501 632.58 NA NA%
2020-07-07 24 750 501 626.38 NA NA%
2020-06-29 24 734 400 610.12 NA NA%
2020-06-23 24 734 400 608.04 NA NA%
2020-06-12 24 734 400 604.08 NA NA%
2020-06-11 24 734 400 600.92 NA NA%
2020-06-01 24 734 400 598.67 NA NA%

REGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.52 7 11 8 0 0 26

The Trend in the Broker Recommendations


REGN's average broker recommendation rating improved by 0 over the prior 52 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • REGN has a greater average analyst price target than 99.23% of all US stocks.
  • Regeneron Pharmaceuticals Inc's number of analysts covering the stock is greater than 99.72% of Pharmaceutical Products stocks.
  • The upside potential (average analyst target price relative to current price) of REGN is greater than 6.73% of Pharmaceutical Products stocks.
  • REGN has a lower variance in analysts' estimates than 32.32% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Regeneron Pharmaceuticals Inc are BIIB, TECH and LLY.

Is REGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.4584 seconds.